Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer.

The likelihood of accomplishing pCR is indicated to be lower in breast cancer patients with higher MD, which need to be analysed in future studies for improved clinical decision-making regarding neoadjuvant treatment.